Hostname: page-component-8448b6f56d-t5pn6 Total loading time: 0 Render date: 2024-04-25T00:25:11.141Z Has data issue: false hasContentIssue false
  • English
  • Français

Apolipoprotein E mutations, type V hyperlipoproteinaemia and diet

Published online by Cambridge University Press:  09 March 2007

Jean Dallongeville
Jean Dallongeville
Affiliation:
Département d'Athérosclérose, Unité INSEM-508, Institut Pasteur de Lille, 1 rue du Professeur Calmette, 59019 Lille Cedex, France
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Invited commentary
Information
British Journal of Nutrition , Volume 83 , Issue 6 , June 2000 , pp. 573 - 574
Copyright
Copyright © The Nutrition Society 2000

References

Dallongeville, JLussier-Cacan, S and Davignon, J (1992) Modulation of plasma triglyceride levels by apo E phenotype: a meta-analysis Journal of Lipid Research 33, 447-454.CrossRefGoogle ScholarPubMed
Ghiselli, G, Gregg, RE, Zech, LA, Schaefer, EJ and Brewer, HBJ (1982) Phenotype study of apolipoprotein E isoforms in hyperlipoproteinaemic patients Lancet 2, 405-407.CrossRefGoogle ScholarPubMed
Ghiselli, G, Schaefer, EJ, Zech, LA, Gregg, RE and Brewer, HBJ (1982) Increased prevalence of apolipoprotein E4 in type V hyperlipoproteinemia Journal of Clinical Investigation 70, 474-477.CrossRefGoogle ScholarPubMed
Kuusi, T, Taskinen, MR, Solakivi, T and Kauppinen-Makelin, R (1988) Role of apolipoproteins E and C in type V hyperlipoproteinemia Journal of Lipid Research 29, 293-298.CrossRefGoogle Scholar
Pocovi, M, Cenarro, A, Civeira, F, Myers, RH, Casao, E, Esteban, M and Ordovas, JM (1996) Incomplete dominance of type III hyperlipoproteinemia is associated with the rare apolipoprotein E2 (Arg136→Ser) variant in multigenerational pedigree studies Atherosclerosis 122, 33-46.CrossRefGoogle ScholarPubMed
Vialettes, B, Raynier, P, Atlan-Gepner, C, Mekki, N, Lesluyes-Mazzochi, L, Luc, G, Lairon, D and Malthiery, Y (2000) Dietary fat clearance in type V hyperlipoproteinaemia secondary to a rare variant of human apolipoprotein E: the apolipoprotein E3 (Arg 136→Ser) British Journal of Nutrition 83, 615-622.CrossRefGoogle Scholar
Wardell, MR, Brennan, SO, Janus, ED, Fraser, R and Carrell, RW (1987) Apolipoprotein E2-Christchurch (136 Arg→Ser). New variant of human apolipoprotein E in a patient with type III hyperlipoproteinemia Journal of Clinical Investigation 80, 483-490.CrossRefGoogle Scholar